Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.145 USD | -1.72% | +0.96% | -2.48% |
Mar. 08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 08 | Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.48% | 226M | |
-1.54% | 105B | |
+3.65% | 97.5B | |
+1.86% | 22.19B | |
-16.47% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.52% | 14.52B | |
+5.16% | 14.09B | |
+26.46% | 10.99B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics : to Join Nasdaq Biotechnology Index